1997
DOI: 10.1007/bf03401669
|View full text |Cite
|
Sign up to set email alerts
|

CD3-ε Overexpressed in Prothymocytes Acts as an Oncogene

Abstract: Background: Upon engagement of the T cell receptor for antigen, its associated CD3 proteins recruit signal transduction molecules, which in turn regulate T lymphocyte proliferation, apoptosis, and thymocyte development. Because some signal transducing molecules re-

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
5
0

Year Published

1997
1997
2020
2020

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 34 publications
0
5
0
Order By: Relevance
“…CD3 overexpression blocks T cell development at a very early stage preceding T cell receptor (TCR) rearrangement (47). CD3 also acts as an oncogene when overexpressed in prothymocytes (48). These findings are especially relevant to the possible consequences of B29 overexpression as CD3 fulfills the same role in the TCR as B29 does in the B cell receptor.…”
Section: Discussionmentioning
confidence: 99%
“…CD3 overexpression blocks T cell development at a very early stage preceding T cell receptor (TCR) rearrangement (47). CD3 also acts as an oncogene when overexpressed in prothymocytes (48). These findings are especially relevant to the possible consequences of B29 overexpression as CD3 fulfills the same role in the TCR as B29 does in the B cell receptor.…”
Section: Discussionmentioning
confidence: 99%
“…The invariant preTCRα gene (which acts as a surrogate for TCRα during T-cell development) has been shown to cooperate with Notch signaling to induce lymphomagenesis in mice (10). More directly, mice transgenic for components of the TCR have been shown to undergo lymphomagenesis, including mice that overexpress a TCRα transgene, mice that overexpress CD3ε, and mice that express truncated versions of TCRβ (11)(12)(13). These findings suggest that the TCR signaling pathway can play a role in driving lymphomagenesis and also bring up the question of whether a completely unmodified TCR expressed at normal levels can be oncogenic.…”
mentioning
confidence: 99%
“…In addition to the gene knockout approach, transgenic expression of genes has been very informative in elucidating the contribution of TCR/aD3 proteins in T-lymphocyte and NK-cell development (20,21). We generated a series of transgenic mice with genomic constructs containing the CD3-e or CD3-5 genes tinder the transcriptional regulation of their endogenous promoters and enhancers (22)(23)(24), Interestingly, we observed an arrest in T-lymphocyte development in many of the lines derived from CD3-e transgenes. which occurred only when these transgenes were expressed at high levels (23), The earhest block in thymocyte development was found in two homozygous CD3-e-transgenic lines: one termed tge26.…”
Section: Fig I Schematic Diagram Of Thymocyte Developmentmentioning
confidence: 99%
“…Consistently, in the CD3-deficient mice (CD3-e"'" (AP/E1/E2) X CD3-^-'^-), thymocyte development is arrested at the later CD44 CD25+ control point, and these animals stiU have a wild-type level of NK cells (Wang et al unpublished data). Taken together, the studies of the CD3-e-transgenic mice have led us to propose that the arrest in T-and NK-cell development in tge26 mice results from a high level of transgene expression which causes excessive apoptotic signaling (23,24). Using BM transplantation, we examined whether the thymic architecture of tge26 mice could be reconstituted by wild-type thymocyte precursors.…”
Section: Fig I Schematic Diagram Of Thymocyte Developmentmentioning
confidence: 99%